PROCEPT BioRobotics Corporation Common Stock PRCT

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

• GlobeNewswire Inc. 30 sept

  LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation

  A lawsuit was filed on July 24, 2026, against PROCEPT BioRobotics Corporation alleging the company misrepresented U.S. handpiece unit sales through an undisclosed discount program that incentivized bulk orders beyond actual demand, artificially inflating reported sales and exposing the company to material operational and financial risks.

  

• GlobeNewswire Inc. 24 sept

  Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf

  Grabar Law Office announced investigations into potential breaches of fiduciary duties by officers and directors at Doximity, GoDaddy, Planet Fitness, and PROCEPT BioRobotics. The investigations follow federal securities class action filings alleging misleading statements regarding business metrics, pricing strategies, and financial guidance. Long-term shareholders meeting specific holding periods are eligible to seek corporate reforms and potential compensation at no cost.

  

• GlobeNewswire Inc. 21 sept

  Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

  A class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly making materially false statements about its business between February 2024 and February 2026. The company allegedly used an undisclosed discount program to artificially inflate handpiece sales, leading to excess inventory of over 10,000 units. Stock price declined significantly following three earnings announcements revealing lower-than-expected sales and inventory issues. Shareholders have until September 22, 2026 to file lead plaintiff motions.

  

• GlobeNewswire Inc. 21 sept

  Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

  Kaplan Fox has filed a class action lawsuit against PROCEPT BioRobotics Corporation for allegedly misleading investors about the relationship between handpiece unit sales and procedures. The complaint alleges that undisclosed discount programs artificially inflated reported U.S. handpiece unit sales and revenues by pulling forward demand. Investors who purchased PROCEPT common stock between February 28, 2024 and February 25, 2026 may be eligible to participate in the class action, with a deadline of September 22, 2026 to seek a lead plaintiff role.

  

• GlobeNewswire Inc. 19 sept

  INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026

  A securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly misleading investors about handpiece sales through undisclosed bulk discount programs that artificially inflated revenues. The company pulled forward sales from future quarters to meet expectations, resulting in excess customer inventory of over 10,000 units. PROCEPT shares declined over 48% from August 2025 to February 2026 as the truth emerged through a series of earnings misses and subsequent disclosures.